Artios Pharma
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
33 W 60th St 1138, New York City, New Yo...Phone Number
(917) 499-3988Website
www.artiospharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Artios Pharma
Artios Pharma is an independent company specializing in DNA Damage Response (DDR) with a focus on developing novel cancer therapies that possess first-in-class and best-in-class potential. The company is committed to pioneering breakthroughs in DDR-based treatments to address a variety of challenging cancers, leveraging an extensive pipeline of product candidates, including ATR and Pol Theta inhibitors. Artios aims to employ its groundbreaking DcoDeR platform to optimize drug combinations and improve patient outcomes, making it a leader in the biotechnology sector for difficult-to-treat solid tumors. Their mission is clear: to improve clinical results and provide lasting benefits to patients through innovative DDR-targeted therapies.Explore more
Popular SearchesArtios Pharma IncArtios Pharma LtdArtios CorpArtios PharmaARTiOSSIC Code 28,283NAICS Code 32,325Show more
Artios Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Artios Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Artios Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Artios Pharma
Check if Artios Pharma has recently received funding, and reach out quickly before it becomes old news!
Click to see if Artios Pharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Artios Pharma has new funding data
Artios Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Artios Pharma recently announced quarterly report
Product Launch: Get notified when Artios Pharma launches new products
Recommended Actions
Find VP level buyers at Artios Pharma
Find 2 more new buyers
Compare Similar Companies to Artios Pharma
Compare insights from companies similar to Artios Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Artios Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Artios Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Artios Pharma.
Artios Pharma Tech Stack
A closer look at the technologies used by Artios Pharma
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Artios Pharma
Sign Up For FreeTo access detailed company insights
Artios Pharma is an independent company specializing in DNA Damage Response (DDR) with a focus on developing novel cancer therapies that possess first-in-class and best-in-class potential. The company is committed to pioneering breakthroughs in DDR-based treatments to address a variety of challenging cancers, leveraging an extensive pipeline of pro... Read More
